Automating Predictive Phage Therapy Pharmacology

被引:2
|
作者
Abedon, Stephen T. [1 ]
机构
[1] Ohio State Univ, Dept Microbiol, Mansfield, OH 44906 USA
来源
ANTIBIOTICS-BASEL | 2023年 / 12卷 / 09期
关键词
active treatment; bacteriophage therapy; biocontrol; biological control; !text type='Java']Java[!/text]Script; MOI; passive treatment; pharmacodynamics; BACTERIOPHAGE THERAPY; GROWTH; POPULATION; ADSORPTION; INFECTION; DYNAMICS; HOST; EFFICIENCY; SYNERGY; SYSTEM;
D O I
10.3390/antibiotics12091423
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Viruses that infect as well as often kill bacteria are called bacteriophages, or phages. Because of their ability to act bactericidally, phages increasingly are being employed clinically as antibacterial agents, an infection-fighting strategy that has been in practice now for over one hundred years. As with antibacterial agents generally, the development as well as practice of this phage therapy can be aided via the application of various quantitative frameworks. Therefore, reviewed here are considerations of phage multiplicity of infection, bacterial likelihood of becoming adsorbed as a function of phage titers, bacterial susceptibility to phages also as a function of phage titers, and the use of Poisson distributions to predict phage impacts on bacteria. Considered in addition is the use of simulations that can take into account both phage and bacterial replication. These various approaches can be automated, i.e., by employing a number of online-available apps provided by the author, the use of which this review emphasizes. In short, the practice of phage therapy can be aided by various mathematical approaches whose implementation can be eased via online automation.
引用
收藏
页数:24
相关论文
共 50 条
  • [31] ALTERNATIVES TO ANTIBIOTICS: PHAGE LYTIC ENZYMES AND PHAGE THERAPY
    Nazarov, P. A.
    BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2018, (01): : 5 - 15
  • [32] Models of virulent phage growth with application to phage therapy
    Smith, Hal L.
    SIAM JOURNAL ON APPLIED MATHEMATICS, 2008, 68 (06) : 1717 - 1737
  • [33] Phage Neutralization by Sera of Patients Receiving Phage Therapy
    Lusiak-Szelachowska, Marzanna
    Zaczek, Maciej
    Weber-Dabrowska, Beata
    Miedzybrodzki, Ryszard
    Klak, Marlena
    Fortuna, Wojciech
    Letkiewicz, Slawomir
    Rogoz, Pawel
    Szufnarowski, Krzysztof
    Jonczyk-Matysiak, Ewa
    Owczarek, Barbara
    Gorski, Andrzej
    VIRAL IMMUNOLOGY, 2014, 27 (06) : 295 - 304
  • [34] Does Phage Therapy Need a Pan-Phage?
    Bozidis, Petros
    Markou, Eleftheria
    Gouni, Athanasia
    Gartzonika, Konstantina
    PATHOGENS, 2024, 13 (06):
  • [35] Knowing and Naming: Phage Annotation and Nomenclature for Phage Therapy
    Grigson, Susanna R.
    Giles, Sarah K.
    Edwards, Robert A.
    Papudeshi, Bhavya
    CLINICAL INFECTIOUS DISEASES, 2023, 77 : S352 - S359
  • [36] Editorial: Standards in personalized phage therapy: from phage collection to phage production
    Kiljunen, Saija
    Resch, Gregory
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [37] Automating predictive maintenance using oil analysis and machine learning
    Keartland, Sarah
    Van Zyl, Terence L.
    2020 INTERNATIONAL SAUPEC/ROBMECH/PRASA CONFERENCE, 2020, : 167 - 172
  • [38] \ The Pharmacology of Gene Therapy
    Yla-Herttuala, Seppo
    MOLECULAR THERAPY, 2017, 25 (08) : 1731 - 1732
  • [39] Phage Therapy Experience at the Eliava Phage Therapy Center: Three Cases of Bacterial Persistence
    Zaldastanishvili, Elisabed
    Leshkasheli, Lika
    Dadiani, Mariam
    Nadareishvili, Lia
    Askilashvili, Lia
    Kvatadze, Nino
    Goderdzishvili, Marina
    Kutateladze, Mzia
    Balarjishvili, Nana
    VIRUSES-BASEL, 2021, 13 (10):
  • [40] The pharmacology of gene therapy
    Minchin, RF
    Orr, RJ
    Cronin, AS
    Puls, RL
    CROATIAN MEDICAL JOURNAL, 1999, 40 (03) : 381 - 391